The protection of rat retinal ganglion cells from ischemia/reperfusion injury by the inhibitory peptide of mitochondrial μ-calpain
- PMID: 27596965
- DOI: 10.1016/j.bbrc.2016.09.006
The protection of rat retinal ganglion cells from ischemia/reperfusion injury by the inhibitory peptide of mitochondrial μ-calpain
Abstract
Intracellular Ca(2+)-dependent cysteine proteases such as calpains have been suggested as critical factors in retinal ganglion cell (RGC) death. However, it is unknown whether mitochondrial calpains are involved in RGC death. The purpose of the present study was to determine whether the inhibition of mitochondrial μ-calpain activity protects against RGC death during ischemia/reperfusion (I/R) injury. This study used a well-established rat model of experimental acute glaucoma involving I/R injury. A specific peptide inhibitor of mitochondrial μ-calpain, Tat-μCL, was topically applied to rats via eye drops three times a day for 5 days after I/R. RGC death was determined by the terminal deoxynucleotidyl transferase dUTP nick end labeling assay. The truncation of apoptosis-inducing factor (AIF) was determined by western blot analyses. Retinal morphology was determined after staining with hematoxyline and eosin. In addition, the number of Fluoro Gold-labeled RGCs in flat-mounted retinas was used to determine the percentage of surviving RGCs after I/R injury. After 1 day of I/R, RGC death was observed in the ganglion cell layer. Treatment with Tat-μCL eye drops significantly prevented the death of RGCs and the truncation of AIF. After 5 days of I/R, RGC death decreased by approximately 40%. However, Tat-μCL significantly inhibited the decrease in the retinal sections and flat-mounted retinas. The results suggested that mitochondrial μ-calpain is associated with RGC death during I/R injury via truncation of AIF. In addition, the inhibition of mitochondrial μ-calpain activity by Tat-μCL had a neuroprotective effect against I/R-induced RGC death.
Keywords: Apoptosis; Apoptosis-inducing factor; Glaucoma; Ischemia/reperfusion injury; Mitochondrial calpain; Retinal ganglion cell.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Inhibitory peptide of mitochondrial μ-calpain protects against photoreceptor degeneration in rhodopsin transgenic S334ter and P23H rats.PLoS One. 2013 Aug 9;8(8):e71650. doi: 10.1371/journal.pone.0071650. eCollection 2013. PLoS One. 2013. PMID: 23951212 Free PMC article.
-
Intravitreal injection or topical eye-drop application of a μ-calpain C2L domain peptide protects against photoreceptor cell death in Royal College of Surgeons' rats, a model of retinitis pigmentosa.Biochim Biophys Acta. 2012 Nov;1822(11):1783-95. doi: 10.1016/j.bbadis.2012.07.018. Epub 2012 Aug 3. Biochim Biophys Acta. 2012. PMID: 22885154
-
A key role for calpains in retinal ganglion cell death.Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5420-30. doi: 10.1167/iovs.07-0287. Invest Ophthalmol Vis Sci. 2007. PMID: 18055788
-
Mechanisms of retinal ganglion cell injury and defense in glaucoma.Exp Eye Res. 2010 Jul;91(1):48-53. doi: 10.1016/j.exer.2010.04.002. Epub 2010 Apr 13. Exp Eye Res. 2010. PMID: 20394744 Free PMC article. Review.
-
Tools and Biomarkers for the Study of Retinal Ganglion Cell Degeneration.Int J Mol Sci. 2022 Apr 13;23(8):4287. doi: 10.3390/ijms23084287. Int J Mol Sci. 2022. PMID: 35457104 Free PMC article. Review.
Cited by
-
Various Forms of Programmed Cell Death Are Concurrently Activated in the Population of Retinal Ganglion Cells after Ischemia and Reperfusion.Int J Mol Sci. 2023 Jun 8;24(12):9892. doi: 10.3390/ijms24129892. Int J Mol Sci. 2023. PMID: 37373037 Free PMC article.
-
Houttuynia cordata Thunb rescues retinal ganglion cells through inhibiting microglia activation in a rat model of retinal ischemia-reperfusion.Int J Ophthalmol. 2020 Dec 18;13(12):1880-1886. doi: 10.18240/ijo.2020.12.06. eCollection 2020. Int J Ophthalmol. 2020. PMID: 33344185 Free PMC article.
-
Multiple types of programmed necrosis such as necroptosis, pyroptosis, oxytosis/ferroptosis, and parthanatos contribute simultaneously to retinal damage after ischemia-reperfusion.Sci Rep. 2022 Oct 13;12(1):17152. doi: 10.1038/s41598-022-22140-0. Sci Rep. 2022. PMID: 36229563 Free PMC article.
-
Calpains as mechanistic drivers and therapeutic targets for ocular disease.Trends Mol Med. 2022 Aug;28(8):644-661. doi: 10.1016/j.molmed.2022.05.007. Epub 2022 May 29. Trends Mol Med. 2022. PMID: 35641420 Free PMC article. Review.
-
Sulforaphane alleviates retinal ganglion cell death and inflammation by suppressing NLRP3 inflammasome activation in a rat model of retinal ischemia/reperfusion injury.Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419861777. doi: 10.1177/2058738419861777. Int J Immunopathol Pharmacol. 2019. PMID: 31266422 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous